Alzheimer's & Dementia

Proteomic signatures of protected APOE ε4 carriers reveal causal pathways associated with delayed Alzheimer's disease onset

By Yann Le Guen, Junyoung Park, Andrés Peña-Tauber, Michael D. Greicius

Study in peopleMechanisms

The paper

Yann Le Guen, Junyoung Park, Andrés Peña-Tauber, Michael D. Greicius

Stanford Medicine; Stanford University

Alzheimer's & Dementia, 1 Aug 2026

doi.org/10.1002/alz.71688 PubMed 42592812

medRxiv4 Oct 2026
APOE disease risks and proteomic links vary by ancestry
Alzheimer's & Dementia6 Oct 2026
Genetic risk scores linked to faster progression to Alzheimer’s
Nature Neuroscience9 Oct 2026
Genetic data highlight potential drug targets for Alzheimer's
Geriatrics & Gerontology International4 Oct 2026
An 11-protein blood score tracks incident dementia risk